Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
MedAdvisor Limited ( (AU:MDR) ) has issued an announcement.
MedAdvisor Limited has received a non-binding Letter of Intent from a multinational software company to acquire its ANZ business division, which the directors believe offers a materially higher value than the current share price. This proposal aligns with MedAdvisor’s strategic review process aimed at bridging the valuation gap of its ANZ and US business units. The ANZ division recently achieved record revenue, and the potential acquirer plans to continue investing in the business, benefiting pharmacies across Australia. The transaction, subject to due diligence, is expected to be finalized within 5 to 7 weeks.
More about MedAdvisor Limited
MedAdvisor Solutions is a global leader in pharmacy-driven patient engagement solutions, offering personalized experiences to simplify the medication journey. Utilizing its cloud-based, AI-enabled platform THRiV, the company enhances pharmacy workflows and patient engagement. MedAdvisor collaborates with over 34,000 pharmacies in the US, reaching more than two-thirds of the population, and is used by over 95% of Australian pharmacies to connect with 3.7 million patients.
Average Trading Volume: 631,599
Technical Sentiment Signal: Sell
Current Market Cap: A$57.38M
For a thorough assessment of MDR stock, go to TipRanks’ Stock Analysis page.